Discriminating prevalent type 2 diabetes among community-dwelling older adults with metabolic dysfunction-associated steatotic liver disease: a comparative analysis of 12 insulin resistance surrogates - Summary - MDSpire

Discriminating prevalent type 2 diabetes among community-dwelling older adults with metabolic dysfunction-associated steatotic liver disease: a comparative analysis of 12 insulin resistance surrogates

  • By

  • Xianshang Zhu

  • Zengrui Wang

  • Yan Fang

  • Zong Ning

  • Xia Yang

  • July 8, 2026

  • 0 min

Share

Objective:

To compare the associations and discriminatory ability of 12 surrogate insulin resistance indexes for prevalent type 2 diabetes mellitus among community-dwelling older adults with metabolic dysfunction-associated fatty liver disease.

Approach:
  • Study Design: Cross-sectional study based on a health examination cohort from a community in northwestern China.
  • Participants: 2641 eligible participants, including 605 older adults with metabolic dysfunction-associated steatotic liver disease.
  • Methods: Multivariable logistic regression, ROC curve analysis, RCS analysis, subgroup analysis, and exploratory internal model-discrimination analyses were performed.
Key Findings:
  • After multivariable adjustment, TyG, TyG-ABSI, TyG-WWI, and TyG-WC were significantly associated with prevalent T2DM (all P < 0.05).
  • TyG showed the highest discriminatory ability (AUC = 0.726, 95% CI: 0.686-0.766) with an optimal cut-off value of 9.225.
  • After Bonferroni correction, TyG performed significantly better than other indicators.
  • TyG remained the best-performing index even after excluding T2DM cases defined solely by fasting plasma glucose (AUC = 0.707).
Interpretation:

TyG and its variants are associated with prevalent T2DM and demonstrate moderate discriminatory ability in older adults with metabolic dysfunction-associated steatotic liver disease.

Limitations:
  • The study is cross-sectional, limiting causal inferences.
  • Data were extracted from routine health examination records, which may have inherent biases.
Conclusion:

TyG is a simple, integrated metabolic marker for identifying prevalent T2DM in older adults with metabolic dysfunction-associated fatty liver disease.

Original Source(s)

Related Content